Search research articles
Contact Us
Filters
Showing results (281-290 of 296) with videos related to
Page
of 30
Sort By:
Kidney International Reports
|
August 11, 2020
Assessing the Impact of Losmapimod on Proteinuria in Idiopathic Focal Segmental Glomerulosclerosis
Debbie S Gipson, Michelle A Hladunewich, Richard Lafayette, et al.
The New England Journal of Medicine
|
November 6, 2025
A Phase 3 Trial of Atacicept in Patients with IgA Nephropathy
Richard Lafayette, Sean J Barbour, Robert M Brenner, et al.
Canadian Journal of Kidney Health and Disease
|
April 22, 2022
The Canadian Glomerulonephritis Registry (CGNR) and Translational Research Initiative: Rationale and Clinical Research Protocol
Ainslie M Hildebrand, Moumita Barua, Sean J Barbour, et al.
Clinical Pharmacokinetics
|
February 15, 2021
Evaluation of the Pharmacokinetics and Exposure-Response Relationship of Dapagliflozin in Patients without Diabetes and with Chronic Kidney Disease
Annemarie B van der Aart-van der Beek, Jeroen V Koomen, Claire C J Dekkers, et al.
JCI Insight
|
February 8, 2022
Immunoglobulin A nephropathy is characterized by anticommensal humoral immune responses
Elissa G Currie, Bryan Coburn, Elisa A Porfilio, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
July 1, 2022
Association of Histologic Parameters with Outcome in C3 Glomerulopathy and Idiopathic Immunoglobulin-Associated Membranoproliferative Glomerulonephritis
Hannah J Lomax-Browne, Nicholas R Medjeral-Thomas, Sean J Barbour, et al.
Kidney International
|
May 25, 2019
Standardized Outcomes in Nephrology-Glomerular Disease (SONG-GD): establishing a core outcome set for trials in patients with glomerular disease
Simon A Carter, Liz Lightstone, Daniel Cattran, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
December 31, 2021
A Core Outcome Set for Trials in Glomerular Disease: A Report of the Standardized Outcomes in Nephrology-Glomerular Disease (SONG-GD) Stakeholder Workshops
Simon A Carter, Liz Lightstone, Dan Cattran, et al.
Kidney International
|
May 8, 2021
Development of an international Delphi survey to establish core outcome domains for trials in adults with glomerular disease
Simon A Carter, Charlotte Logeman, Martin Howell, et al.
Nephron
|
June 20, 2015
A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR)
Fernando C Fervenza, Pietro A Canetta, Sean J Barbour, et al.
Page
of 30
Search research articles
Search
Showing results (281-290 of 296) with videos related to
Sort By:
Page
of 30
Kidney International Reports
|
August 11, 2020
Assessing the Impact of Losmapimod on Proteinuria in Idiopathic Focal Segmental Glomerulosclerosis
Debbie S Gipson, Michelle A Hladunewich, Richard Lafayette, et al.
The New England Journal of Medicine
|
November 6, 2025
A Phase 3 Trial of Atacicept in Patients with IgA Nephropathy
Richard Lafayette, Sean J Barbour, Robert M Brenner, et al.
Canadian Journal of Kidney Health and Disease
|
April 22, 2022
The Canadian Glomerulonephritis Registry (CGNR) and Translational Research Initiative: Rationale and Clinical Research Protocol
Ainslie M Hildebrand, Moumita Barua, Sean J Barbour, et al.
Clinical Pharmacokinetics
|
February 15, 2021
Evaluation of the Pharmacokinetics and Exposure-Response Relationship of Dapagliflozin in Patients without Diabetes and with Chronic Kidney Disease
Annemarie B van der Aart-van der Beek, Jeroen V Koomen, Claire C J Dekkers, et al.
JCI Insight
|
February 8, 2022
Immunoglobulin A nephropathy is characterized by anticommensal humoral immune responses
Elissa G Currie, Bryan Coburn, Elisa A Porfilio, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
July 1, 2022
Association of Histologic Parameters with Outcome in C3 Glomerulopathy and Idiopathic Immunoglobulin-Associated Membranoproliferative Glomerulonephritis
Hannah J Lomax-Browne, Nicholas R Medjeral-Thomas, Sean J Barbour, et al.
Kidney International
|
May 25, 2019
Standardized Outcomes in Nephrology-Glomerular Disease (SONG-GD): establishing a core outcome set for trials in patients with glomerular disease
Simon A Carter, Liz Lightstone, Daniel Cattran, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
December 31, 2021
A Core Outcome Set for Trials in Glomerular Disease: A Report of the Standardized Outcomes in Nephrology-Glomerular Disease (SONG-GD) Stakeholder Workshops
Simon A Carter, Liz Lightstone, Dan Cattran, et al.
Kidney International
|
May 8, 2021
Development of an international Delphi survey to establish core outcome domains for trials in adults with glomerular disease
Simon A Carter, Charlotte Logeman, Martin Howell, et al.
Nephron
|
June 20, 2015
A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR)
Fernando C Fervenza, Pietro A Canetta, Sean J Barbour, et al.
Page
of 30